Enrique Brandan - Publications

Affiliations: 
Departamento de Biologia Celular y Molecular Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile 

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Córdova-Casanova A, Cruz-Soca M, Chun J, Casar JC, Brandan E. Activation of the ATX/LPA/LPARs axis induces a fibrotic response in skeletal muscle. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 35385768 DOI: 10.1016/j.matbio.2022.03.008  0.387
2021 Rebolledo DL, Lipson KE, Brandan E. Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF). Matrix Biology Plus. 11: 100059. PMID 34435178 DOI: 10.1016/j.mbplus.2021.100059  0.379
2021 Rebolledo DL, Acuña MJ, Brandan E. Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides. International Journal of Molecular Sciences. 22. PMID 34063397 DOI: 10.3390/ijms22105234  0.342
2021 Contreras O, Córdova-Casanova A, Brandan E. PDGF-PDGFR network differentially regulates, myogenic cell fate, migration, proliferation, and cell cycle progression. Cellular Signalling. 110036. PMID 33971280 DOI: 10.1016/j.cellsig.2021.110036  0.343
2021 Gutiérrez J, Gonzalez D, Escalona-Rivano R, Takahashi C, Brandan E. Reduced RECK levels accelerate skeletal muscle differentiation, improve muscle regeneration, and decrease fibrosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21503. PMID 33811686 DOI: 10.1096/fj.202001646RR  0.389
2021 Gallardo FS, Córdova-Casanova A, Brandan E. The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target? Journal of Cell Communication and Signaling. PMID 33689121 DOI: 10.1007/s12079-021-00610-w  0.324
2020 Contreras O, Soliman H, Theret M, Rossi FMV, Brandan E. TGF-β-driven downregulation of the Wnt/β-Catenin transcription factor TCF7L2/TCF4 in PDGFRα fibroblasts. Journal of Cell Science. PMID 32434871 DOI: 10.1242/Jcs.242297  0.354
2020 Valle-Tenney R, Rebolledo D, Acuña MJ, Brandan E. HIF-hypoxia signaling in skeletal muscle physiology and fibrosis. Journal of Cell Communication and Signaling. PMID 32088838 DOI: 10.1007/S12079-020-00553-8  0.42
2019 Contreras O, Rossi FM, Brandan E. Adherent muscle connective tissue fibroblasts are phenotypically and biochemically equivalent to stromal fibro/adipogenic progenitors. Matrix Biology Plus. 2: 100006. PMID 33543006 DOI: 10.1016/j.mbplus.2019.04.003  0.337
2019 Valle-Tenney R, Rebolledo D, Lipson KE, Brandan E. Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 31669521 DOI: 10.1016/J.Matbio.2019.09.003  0.437
2019 Contreras O, Cruz-Soca M, Theret M, Soliman H, Tung LW, Groppa E, Rossi FM, Brandan E. The cross-talk between TGF-β and PDGFRα signaling pathways regulates stromal fibro/adipogenic progenitors' fate. Journal of Cell Science. PMID 31434718 DOI: 10.1242/Jcs.232157  0.361
2019 Rebolledo DL, González D, Faundez-Contreras J, Contreras O, Vio CP, Murphy-Ullrich JE, Lipson KE, Brandan E. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 30716392 DOI: 10.1016/J.Matbio.2019.01.002  0.417
2019 Gonzalez D, Brandan E. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases. Molecular Neurobiology. PMID 30689195 DOI: 10.1007/S12035-019-1490-9  0.435
2019 Contreras O, Rebolledo D, Oyarzún J, Brandan E. Fibroblasts (Tcf4) and mesenchymal progenitors (PDGFRα) correspond to the same cell type and are increased in skeletal muscle dystrophy, denervation and chronic damage F1000research. 8. DOI: 10.7490/F1000Research.1116478.1  0.422
2019 Contreras O, Rossi FM, Brandan E. Adherent muscle connective tissue fibroblasts are phenotypically and biochemically equivalent to stromal fibro/adipogenic progenitors Matrix Biology Plus. 2: 100006. DOI: 10.1016/J.MBPLUS.2019.04.003  0.303
2018 Gonzalez D, Rebolledo DL, Correa LM, Court F, Cerpa W, Lipson KE, van Zundert B, Brandan E. The inhibition of CTGF/CCN2 activity improves muscle and locomotor function in a murine ALS model. Human Molecular Genetics. PMID 29860398 DOI: 10.1093/Hmg/Ddy204  0.386
2018 Contreras O, Villarreal M, Brandan E. Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation. Skeletal Muscle. 8: 5. PMID 29463296 DOI: 10.1186/S13395-018-0150-5  0.34
2017 Riquelme-Guzman C, Contreras O, Brandan E. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis. American Journal of Physiology. Cell Physiology. PMID 29351412 DOI: 10.1152/Ajpcell.00013.2017  0.452
2017 Acuña MJ, Salas D, Córdova-Casanova A, Cruz-Soca M, Céspedes C, Vio CP, Brandan E. Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors. Journal of Cell Communication and Signaling. PMID 29250740 DOI: 10.1007/S12079-017-0439-X  0.384
2017 Morales MG, Acuña MJ, Cabrera D, Goldschmeding R, Brandan E. The pro-fibrotic connective tissue growth factor (CTGF/CCN2) correlates with the number of necrotic-regenerative foci in dystrophic muscle. Journal of Cell Communication and Signaling. PMID 28887614 DOI: 10.1007/S12079-017-0409-3  0.434
2017 Gonzalez D, Contreras O, Rebolledo DL, Espinoza JP, van Zundert B, Brandan E. ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers. Plos One. 12: e0177649. PMID 28520806 DOI: 10.1371/Journal.Pone.0177649  0.474
2017 Acuña MJ, Brandan E. Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy. Methods in Molecular Biology (Clifton, N.J.). 1489: 513-521. PMID 27734402 DOI: 10.1007/978-1-4939-6430-7_43  0.452
2016 Contreras O, Brandan E. Fibro/adipogenic progenitors safeguard themselves: a novel mechanism to reduce fibrosis is discovered. Journal of Cell Communication and Signaling. PMID 28000149 DOI: 10.1007/S12079-016-0372-4  0.39
2016 Morales MG, Abrigo J, Acuña MJ, Santos RA, Bader M, Brandan E, Simon F, Olguin H, Cabrera D, Cabello-Verrugio C. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy via the Mas receptor. Disease Models & Mechanisms. PMID 26851244 DOI: 10.1242/Dmm.023390  0.446
2016 Contreras O, Rebolledo DL, Oyarzún JE, Olguín HC, Brandan E. Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis. Cell and Tissue Research. PMID 26742767 DOI: 10.1007/S00441-015-2343-0  0.477
2015 Fuenzalida M, Espinoza C, Pérez MÁ, Tapia-Rojas C, Cuitino L, Brandan E, Inestrosa NC. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Neurobiology of Disease. PMID 26626079 DOI: 10.1016/J.Nbd.2015.11.018  0.465
2015 Gutiérrez J, Droppelmann CA, Contreras O, Takahashi C, Brandan E. RECK-Mediated β1-Integrin Regulation by TGF-β1 Is Critical for Wound Contraction in Mice. Plos One. 10: e0135005. PMID 26247610 DOI: 10.1371/Journal.Pone.0135005  0.338
2015 Cofre C, José Acuña M, Contreras O, Gabriela Morales M, Riquelme C, Bader M, Santos R, Cabello-Verrugio C, Brandan E. Erratum for: Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies. Biofactors (Oxford, England). 41: 209. PMID 26094753 DOI: 10.1002/Biof.1220  0.355
2015 Morales MG, Olguin H, Di Capua G, Brandan E, Simon F, Cabello-Verrugio C. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin (1-7) through a p38 MAPK dependent mechanism. Clinical Science (London, England : 1979). PMID 25989282 DOI: 10.1042/Cs20140840  0.439
2015 Cofre C, Acuña MJ, Contreras O, Morales MG, Riquelme C, Cabello-Verrugio C, Brandan E. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies. Biofactors (Oxford, England). 41: 111-20. PMID 25809912 DOI: 10.1002/Biof.1208  0.434
2015 Córdova G, Rochard A, Riquelme-Guzmán C, Cofré C, Scherman D, Bigey P, Brandan E. SMAD3 and SP1/SP3 Transcription Factors Collaborate to Regulate Connective Tissue Growth Factor Gene Expression in Myoblasts in Response to Transforming Growth Factor β. Journal of Cellular Biochemistry. 116: 1880-7. PMID 25727481 DOI: 10.1002/Jcb.25143  0.366
2015 Cisternas F, Morales MG, Meneses C, Simon F, Brandan E, Abrigo J, Vazquez Y, Cabello-Verrugio C. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism. Clinical Science (London, England : 1979). 128: 307-19. PMID 25222828 DOI: 10.1042/Cs20140215  0.441
2014 Meneses C, Morales MG, Abrigo J, Simon F, Brandan E, Cabello-Verrugio C. The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice. Pflugers Archiv : European Journal of Physiology. PMID 25292283 DOI: 10.1007/S00424-014-1617-9  0.394
2014 Pessina P, Cabrera D, Morales MG, Riquelme CA, Gutiérrez J, Serrano AL, Brandan E, Muñoz-Cánoves P. Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy. Skeletal Muscle. 4: 7. PMID 25157321 DOI: 10.1186/2044-5040-4-7  0.412
2014 Riquelme C, Acuña MJ, Torrejón J, Rebolledo D, Cabrera D, Santos RA, Brandan E. ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. Plos One. 9: e93449. PMID 24695436 DOI: 10.1371/Journal.Pone.0093449  0.46
2014 Cabrera D, Gutiérrez J, Cabello-Verrugio C, Morales MG, Mezzano S, Fadic R, Casar JC, Hancke JL, Brandan E. Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis. Skeletal Muscle. 4: 6. PMID 24655808 DOI: 10.1186/2044-5040-4-6  0.448
2014 Gutiérrez J, Cabrera D, Brandan E. Glypican-1 regulates myoblast response to HGF via Met in a lipid raft-dependent mechanism: effect on migration of skeletal muscle precursor cells. Skeletal Muscle. 4: 5. PMID 24517345 DOI: 10.1186/2044-5040-4-5  0.436
2014 Acuña MJ, Pessina P, Olguin H, Cabrera D, Vio CP, Bader M, Muñoz-Canoves P, Santos RA, Cabello-Verrugio C, Brandan E. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling. Human Molecular Genetics. 23: 1237-49. PMID 24163134 DOI: 10.1093/Hmg/Ddt514  0.463
2014 Cisternas P, Henriquez JP, Brandan E, Inestrosa NC. Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis. Molecular Neurobiology. 49: 574-89. PMID 24014138 DOI: 10.1007/S12035-013-8540-5  0.611
2013 Morales MG, Gutierrez J, Cabello-Verrugio C, Cabrera D, Lipson KE, Goldschmeding R, Brandan E. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Human Molecular Genetics. 22: 4938-51. PMID 23904456 DOI: 10.1093/Hmg/Ddt352  0.459
2013 Morales MG, Cabrera D, Céspedes C, Vio CP, Vazquez Y, Brandan E, Cabello-Verrugio C. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). Cell and Tissue Research. 353: 173-87. PMID 23673415 DOI: 10.1007/S00441-013-1642-6  0.464
2013 Brandan E, Gutierrez J. Role of skeletal muscle proteoglycans during myogenesis. Matrix Biology : Journal of the International Society For Matrix Biology. 32: 289-97. PMID 23583522 DOI: 10.1016/J.Matbio.2013.03.007  0.454
2013 Brandan E, Gutierrez J. Role of proteoglycans in the regulation of the skeletal muscle fibrotic response. The Febs Journal. 280: 4109-17. PMID 23560928 DOI: 10.1111/Febs.12278  0.461
2013 Painemal P, Acuña MJ, Riquelme C, Brandan E, Cabello-Verrugio C. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. Biofactors (Oxford, England). 39: 467-75. PMID 23460581 DOI: 10.1002/Biof.1087  0.446
2012 Morales MG, Vazquez Y, Acuña MJ, Rivera JC, Simon F, Salas JD, Alvarez Ruf J, Brandan E, Cabello-Verrugio C. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. The International Journal of Biochemistry & Cell Biology. 44: 1993-2002. PMID 22964022 DOI: 10.1016/J.Biocel.2012.07.028  0.386
2012 Cabello-Verrugio C, Santander C, Cofré C, Acuña MJ, Melo F, Brandan E. The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal muscles. The Journal of Biological Chemistry. 287: 6773-87. PMID 22203668 DOI: 10.1074/Jbc.M111.312488  0.384
2012 Cabello-Verrugio C, Morales MG, Cabrera D, Vio CP, Brandan E. Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. Journal of Cellular and Molecular Medicine. 16: 752-64. PMID 21645240 DOI: 10.1111/J.1582-4934.2011.01354.X  0.482
2011 Morales MG, Cabello-Verrugio C, Santander C, Cabrera D, Goldschmeding R, Brandan E. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. The Journal of Pathology. 225: 490-501. PMID 21826667 DOI: 10.1002/Path.2952  0.475
2011 Cabello-Verrugio C, Acuña MJ, Morales MG, Becerra A, Simon F, Brandan E. Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Biochemical and Biophysical Research Communications. 410: 665-70. PMID 21693104 DOI: 10.1016/J.Bbrc.2011.06.051  0.343
2011 Vial C, Gutiérrez J, Santander C, Cabrera D, Brandan E. Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. The Journal of Biological Chemistry. 286: 24242-52. PMID 21454550 DOI: 10.1074/Jbc.M110.189365  0.345
2011 Cabello-Verrugio C, Córdova G, Vial C, Zúñiga LM, Brandan E. Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway. Cellular Signalling. 23: 449-57. PMID 20965247 DOI: 10.1016/J.Cellsig.2010.10.019  0.359
2010 Droguett R, Cabello-Verrugio C, Santander C, Brandan E. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Experimental Cell Research. 316: 2487-503. PMID 20471380 DOI: 10.1016/J.Yexcr.2010.04.031  0.4
2010 Ugarte G, Santander C, Brandan E. Syndecan-4 and beta1 integrin are regulated by electrical activity in skeletal muscle: Implications for cell adhesion. Matrix Biology : Journal of the International Society For Matrix Biology. 29: 383-92. PMID 20362053 DOI: 10.1016/J.Matbio.2010.03.003  0.438
2010 Gutiérrez J, Brandan E. A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation. Molecular and Cellular Biology. 30: 1634-49. PMID 20100867 DOI: 10.1128/Mcb.01164-09  0.442
2009 Osses N, Casar JC, Brandan E. Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism. Bmc Cell Biology. 10: 73. PMID 19804635 DOI: 10.1186/1471-2121-10-73  0.482
2009 Droppelmann CA, Gutiérrez J, Vial C, Brandan E. Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. The Journal of Biological Chemistry. 284: 13551-61. PMID 19276073 DOI: 10.1074/Jbc.M807352200  0.351
2008 Brandan E, Cabello-Verrugio C, Vial C. Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biology : Journal of the International Society For Matrix Biology. 27: 700-8. PMID 18694824 DOI: 10.1016/J.Matbio.2008.07.004  0.431
2008 Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L, Oliver N, Aten J, Joles JA, Vial C, Brandan E, Lyons KM, Goldschmeding R. CTGF inhibits BMP-7 signaling in diabetic nephropathy. Journal of the American Society of Nephrology : Jasn. 19: 2098-107. PMID 18632843 DOI: 10.1681/Asn.2007111261  0.302
2008 Colombres M, Henríquez JP, Reig GF, Scheu J, Calderón R, Alvarez A, Brandan E, Inestrosa NC. Heparin activates Wnt signaling for neuronal morphogenesis. Journal of Cellular Physiology. 216: 805-15. PMID 18449906 DOI: 10.1002/Jcp.21465  0.498
2008 Vial C, Zúñiga LM, Cabello-Verrugio C, Cañón P, Fadic R, Brandan E. Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. Journal of Cellular Physiology. 215: 410-21. PMID 18064627 DOI: 10.1002/Jcp.21324  0.489
2007 Mezzano V, Cabrera D, Vial C, Brandan E. Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2. Journal of Cell Communication and Signaling. 1: 205-17. PMID 18600480 DOI: 10.1007/S12079-008-0018-2  0.439
2007 Cabello-Verrugio C, Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. The Journal of Biological Chemistry. 282: 18842-50. PMID 17485468 DOI: 10.1074/Jbc.M700243200  0.329
2006 Fadic R, Mezzano V, Alvarez K, Cabrera D, Holmgren J, Brandan E. Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. Journal of Cellular and Molecular Medicine. 10: 758-69. PMID 16989735 DOI: 10.1111/J.1582-4934.2006.Tb00435.X  0.478
2006 Brandan E, Retamal C, Cabello-Verrugio C, Marzolo MP. The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin. The Journal of Biological Chemistry. 281: 31562-71. PMID 16936287 DOI: 10.1074/Jbc.M602919200  0.35
2006 Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biology : Journal of the International Society For Matrix Biology. 25: 332-41. PMID 16766169 DOI: 10.1016/J.Matbio.2006.04.004  0.412
2006 Ugarte G, Brandan E. Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability. The Journal of Biological Chemistry. 281: 18473-81. PMID 16682418 DOI: 10.1074/Jbc.M600918200  0.411
2006 Osses N, Gutierrez J, Lopez-Rovira T, Ventura F, Brandan E. Sulfation is required for bone morphogenetic protein 2-dependent Id1 induction. Biochemical and Biophysical Research Communications. 344: 1207-15. PMID 16647687 DOI: 10.1016/J.Bbrc.2006.04.029  0.362
2006 Santander C, Brandan E. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway. Cellular Signalling. 18: 1482-91. PMID 16413747 DOI: 10.1016/J.Cellsig.2005.11.011  0.322
2006 Gutierrez J, Osses N, Brandan E. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. Journal of Cellular Physiology. 206: 58-67. PMID 15920756 DOI: 10.1002/Jcp.20428  0.345
2005 Moreno M, Muñoz R, Aroca F, Labarca M, Brandan E, Larraín J. Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. The Embo Journal. 24: 1397-405. PMID 15775969 DOI: 10.1038/Sj.Emboj.7600615  0.331
2004 Araya R, Riquelme MA, Brandan E, Sáez JC. The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP. Brain Research. Brain Research Reviews. 47: 174-88. PMID 15572171 DOI: 10.1016/J.Brainresrev.2004.06.003  0.376
2004 Aldunate R, Casar JC, Brandan E, Inestrosa NC. Structural and functional organization of synaptic acetylcholinesterase Brain Research Reviews. 47: 96-104. PMID 15572165 DOI: 10.1016/J.Brainresrev.2004.07.019  0.536
2004 Casar JC, McKechnie BA, Fallon JR, Young MF, Brandan E. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Developmental Biology. 268: 358-71. PMID 15063173 DOI: 10.1016/J.Ydbio.2003.12.025  0.477
2004 Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: Requirement of syndecan-3 for successful fiber formation Journal of Cell Science. 117: 73-84. PMID 14627628 DOI: 10.1242/Jcs.00828  0.629
2004 Villena J, Brandan E. Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration. Journal of Cellular Physiology. 198: 169-78. PMID 14603519 DOI: 10.1002/Jcp.10422  0.453
2003 Olguin HC, Santander C, Brandan E. Inhibition of myoblast migration via decorin expression is critical for normal skeletal muscle differentiation. Developmental Biology. 259: 209-24. PMID 12871697 DOI: 10.1016/S0012-1606(03)00180-5  0.503
2003 Lopez-Casillas F, Riquelme C, Perez-Kato Y, Ponce-Castaneda MV, Osses N, Esparza-Lopez J, Gonzalez-Nunez G, Cabello-Verrugio C, Mendoza V, Troncoso V, Brandan E. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. The Journal of Biological Chemistry. 278: 382-90. PMID 12399463 DOI: 10.1074/Jbc.M208520200  0.404
2002 Henriquez JP, Casar JC, Fuentealba L, Carey DJ, Brandan E. Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. Journal of Cell Science. 115: 2041-51. PMID 11973346  0.335
2002 Alvarez K, Fadic R, Brandan E. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy. Journal of Cellular Biochemistry. 85: 703-13. PMID 11968010 DOI: 10.1002/Jcb.10184  0.47
2002 Osses N, Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. American Journal of Physiology. Cell Physiology. 282: C383-94. PMID 11788350 DOI: 10.1152/Ajpcell.00322.2001  0.483
2001 Olguin H, Brandan E. Expression and localization of proteoglycans during limb myogenic activation Developmental Dynamics. 221: 106-115. PMID 11357198 DOI: 10.1002/Dvdy.1129  0.469
2001 Riquelme C, Larraín J, Schönherr E, Henriquez JP, Kresse H, Brandan E. Antisense Inhibition of Decorin Expression in Myoblasts Decreases Cell Responsiveness to Transforming Growth Factor α and Accelerates Skeletal Muscle Differentiation Journal of Biological Chemistry. 276: 3589-3596. PMID 11071883 DOI: 10.1074/Jbc.M004602200  0.439
2000 Cáceres S, Cuellar C, Casar JC, Garrido J, Schaefer L, Kresse H, Brandan E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle European Journal of Cell Biology. 79: 173-181. PMID 10777109 DOI: 10.1078/S0171-9335(04)70020-5  0.454
1999 Fuentealba L, Carey DJ, Brandan E. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism Journal of Biological Chemistry. 274: 37876-37884. PMID 10608853 DOI: 10.1074/Jbc.274.53.37876  0.466
1999 Villar MJ, Hassell JR, Brandan E. Interaction of skeletal muscle cells with collagen type IV is mediated by perlecan associated with the cell surface Journal of Cellular Biochemistry. 75: 665-674. PMID 10572249 DOI: 10.1002/(Sici)1097-4644(19991215)75:4<665::Aid-Jcb12>3.0.Co;2-S  0.417
1999 Larraín J, Carey DJ, Brandan E. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism Journal of Biological Chemistry. 273: 32288-32296. PMID 9822708 DOI: 10.1074/Jbc.273.48.32288  0.429
1998 Schönherr E, Broszat M, Brandan E, Bruckner P, Kresse H. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Archives of Biochemistry and Biophysics. 355: 241-8. PMID 9675033 DOI: 10.1006/Abbi.1998.0720  0.307
1997 Larraín J, Alvarez J, Hassell JR, Brandan E. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation Experimental Cell Research. 234: 405-412. PMID 9260911 DOI: 10.1006/Excr.1997.3648  0.488
1997 Larraín J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation: Modulation by growth factors and retinoic acid Journal of Biological Chemistry. 272: 18418-18424. PMID 9218485 DOI: 10.1074/Jbc.272.29.18418  0.391
1997 Cáceres J, Brandan E. Interaction between Alzheimer's disease βA4 precursor protein (APP) and the extracellular matrix: Evidence for the participation of heparan sulfate proteoglycans Journal of Cellular Biochemistry. 65: 145-158. PMID 9136074 DOI: 10.1002/(Sici)1097-4644(199705)65:2<145::Aid-Jcb2>3.0.Co;2-U  0.311
1996 Brandan E, Carey DJ, Larraín J, Melo F, Campos A. Synthesis and processing of glypican during differentiation of skeletal muscle cells European Journal of Cell Biology. 71: 170-176. PMID 8905294  0.327
1996 Melo F, Carey DJ, Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression Journal of Cellular Biochemistry. 62: 227-239. PMID 8844403 DOI: 10.1002/(Sici)1097-4644(199608)62:2<227::Aid-Jcb11>3.0.Co;2-I  0.493
1995 Rodriguez SR, Riquelme C, Campos EO, Chavez P, Brandan E, Inestrosa NC. Behavioral Responses of Concholepas concholepas (Bruguière, 1789) Larvae to Natural and Artificial Settlement Cues and Microbial Films. The Biological Bulletin. 189: 272-279. PMID 29244580 DOI: 10.2307/1542144  0.459
1994 Brandan E. Proteoglycans in skeletal muscle Brazilian Journal of Medical and Biological Research. 27: 2109-2116. PMID 7787794  0.355
1993 Melo F, Brandan E. Decorin is specifically solubilized by heparin from the extracellular matrix of rat skeletal muscles Febs Letters. 319: 249-252. PMID 8458417 DOI: 10.1016/0014-5793(93)80556-A  0.447
1993 Campos A, Núñez R, Koenig CS, Carey DJ, Brandan E. A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Isolation and biochemical characterization. European Journal of Biochemistry / Febs. 216: 587-95. PMID 8397086 DOI: 10.1111/J.1432-1033.1993.Tb18178.X  0.406
1993 Brandan E, Inestrosa NC. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. General Pharmacology. 24: 1063-8. PMID 8270163 DOI: 10.1016/0306-3623(93)90350-7  0.482
1992 Gonzalez R, Urrea R, Gonzalez M, Inestrosa NC, Brandan E. Isolation of proteoglycans synthesized by rat heart: evidence for the presence of several distinct forms. General Pharmacology. 23: 249-55. PMID 1639240 DOI: 10.1016/0306-3623(92)90020-K  0.476
1992 Brandan E, Fuentes ME, Andrade W. Decorin, a chondroitin/dermatan sulfate proteoglycan is under neural control in rat skeletal muscle. Journal of Neuroscience Research. 32: 51-9. PMID 1629944 DOI: 10.1002/Jnr.490320107  0.469
1992 Brandan E, González M, Inestrosa NC, Tremblay C, Urrea R. A high molecular weight proteoglycan is differentially expressed during development of the mollusc Concholepas concholepas (Mollusca; Gastropoda; Muricidae). The Journal of Experimental Zoology. 264: 363-71. PMID 1460434 DOI: 10.1002/Jez.1402640402  0.511
1992 Alvarez J, Moreno RD, Llanos O, Inestrosa NC, Brandan E, Colby T, Esch FS. Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. Neuroscience Letters. 144: 130-4. PMID 1436693 DOI: 10.1016/0304-3940(92)90733-N  0.463
1992 Urrea R, González M, Inestrosa NC, Brandan E. Sulfation is required for mobility of veliger larvae ofConcholepas concholepas (Mollusca; Gastropoda; Muricidae) Journal of Experimental Zoology. 261: 365-372. DOI: 10.1002/Jez.1402610402  0.3
1991 Brandan E, Fuentes ME, Andrade W. The proteoglycan decorin is synthesized and secreted by differentiated myotubes. European Journal of Cell Biology. 55: 209-16. PMID 1935986  0.359
1991 Andrade W, Brandan E. Isolation and characterization of rat skeletal muscle proteoglycan decorin and comparison with the human fibroblast decorin Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 100: 565-570. PMID 1814683 DOI: 10.1016/0305-0491(91)90221-X  0.412
1990 Fadic R, Brandan E, Inestrosa NC. Motor nerve regulates muscle extracellular matrix proteoglycan expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3516-23. PMID 2230941 DOI: 10.1523/Jneurosci.10-11-03516.1990  0.599
1990 Perelman A, Abeijon C, Hirschberg CB, Inestrosa NC, Brandan E. Differential association and distribution of acetyl- and butyrylcholinesterases within rat liver subcellular organelles. The Journal of Biological Chemistry. 265: 214-20. PMID 2152920  0.414
1990 Inestrosa NC, Labarca R, Perelman A, Campos EO, Araneda R, Gonzalez M, Brandan E, Sanchez JP, Gonzalez-Plaza R. Biotechnological aspects in loco larvae Archivos De Biologia Y Medicina Experimentales. 23: 179-186. PMID 1966831  0.424
1990 Brandan E, González M, González-Plaza R, Inestrosa NC. Increase of macromolecule synthesis after hatching of Concholepas concholepas veliger larvae: Effect of sulfate in the synthesis of proteoglycans Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 96: 613-619. DOI: 10.1016/0305-0491(90)90065-2  0.48
1990 Gonzalez M, Perelman A, Fuentes ME, Castilla JC, Labarca R, Brandan E, Gonzalez-Plaza R, Inestrosa NC. Neurotransmitter-related enzyme acetylcholinesterase in juveniles of Concholepas concholepas (mollusca; gastropoda; muricidae) Journal of Experimental Zoology. 255: 1-8. DOI: 10.1002/Jez.1402550102  0.483
1987 Brandan E, Inestrosa NC. Co-solubilization of asymmetric acetylcholinesterase and dermatan sulfate proteoglycan from the extracellular matrix of rat skeletal muscles. Febs Letters. 213: 159-63. PMID 3556575 DOI: 10.1016/0014-5793(87)81483-7  0.603
1987 Brandan E, Inestrosa NC. Isolation of the heparan sulfate proteoglycans from the extracellular matrix of rat skeletal muscle. Journal of Neurobiology. 18: 271-82. PMID 2955079 DOI: 10.1002/Neu.480180303  0.597
1987 Inestrosa NC, Nader HB, Garrido J, Sampaio LO, Brandan E, Dietrich CP. Glycosaminoglycan composition of electric organ basement membranes. Journal of Neuroscience Research. 17: 256-64. PMID 2439701 DOI: 10.1002/Jnr.490170309  0.471
1986 Brandan E, Llona I, Inestrosa NC. Heparin-acetylcholinesterase interaction: Specific detachment of class I-A forms and binding of class I and II-A forms to heparin-agarose. Neurochemistry International. 9: 75-84. PMID 20493103 DOI: 10.1016/0197-0186(86)90034-3  0.497
1986 Brandan E, Inestrosa NC. The synaptic form of acetylcholinesterase binds to cell-surface heparan sulfate proteoglycans. Journal of Neuroscience Research. 15: 185-96. PMID 2937928 DOI: 10.1002/Jnr.490150208  0.505
1985 Brandan E, Maldonado M, Garrido J, Inestrosa NC. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. The Journal of Cell Biology. 101: 985-92. PMID 3161900 DOI: 10.1083/Jcb.101.3.985  0.526
1984 Brandan E, Inestrosa NC. Binding of the asymmetric forms of acetylcholinesterase to heparin. The Biochemical Journal. 221: 415-22. PMID 6089739 DOI: 10.1042/Bj2210415  0.521
Show low-probability matches.